Clinical Trial Update: QLS5212 for Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for QLS5212 in participants with advanced solid tumors, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• QLS5212

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Solid Tumor Cancer | Phase 1 | Status: NOT_YET_RECRUITING